Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The process is iterative: genetic improvements are followed by optimization of growth conditions to fully exploit new capabilities, and this cycle continues for cumulative enhancement.
Saccharomyces cerevisiae serves as a prime example of such efforts. Traditionally used in baking, brewing, and bioethanol production, S. cerevisiae has undergone significant enhancement using various tools. These include the selection of natural variants, such as flocculating yeasts in beer production or high-yield wine strains from successful vats, although such methods are slow and offer limited control. To expedite progress, induced mutagenesis through UV or EMS exposure and recombination techniques like protoplast fusion have been widely used to generate high-performing strains.
The advent of recombinant DNA technology enabled targeted interventions, such as gene overexpression or deletion, and paved the way for introducing novel pathways, especially for the production of non-native compounds. Additionally, synthetic biology and CRISPR-Cas9 genome editing now offer precise and predictable strain redesign, integrating systems biology insights to rewire cellular metabolism for optimal output. For example, engineered S. cerevisiae strains with enhanced glycolytic flux and ethanol tolerance have significantly improved bioethanol production. However, improvements may demand costlier fermentation infrastructure, including better aeration, foam control, and novel extraction systems. Despite these trade-offs, strain improvement remains one of the most effective strategies to boost profitability, rooted in understanding and manipulating the organism’s genome and enzymatic capabilities. As such, industrial strain development continues to evolve by building upon both classical and modern genetic techniques.
Wild-type strains may not meet large-scale productivity requirements, so industrial production often benefits from strains optimized beyond the wild type.
Several methods are employed to improve strains, including the isolation of desirable natural variants, the induction of mutations, and targeted metabolic engineering.
In large-scale ethanol production, improved strains of Saccharomyces cerevisiae are routinely used.
Wild-type Saccharomyces cerevisiae cultures are deliberately exposed to high ethanol concentrations that are gradually increased over many generations to impose selective pressure.
This process allows the selection of variants with increased ethanol tolerance and often improved fermentation performance.
In addition, targeted metabolic engineering in these strains can increase ethanol yield by overexpressing key glycolysis and fermentation genes, such as pyruvate kinase and alcohol dehydrogenase, and by reducing the competing by-product genes.
Collectively, these approaches have enhanced S. cerevisiae strains for industrial-scale ethanol production.
繁體中文
